OGT Licenses Southern Array Patents to Taiwan's Phalanx Biotech Group

Nov 01, 2007

NEW YORK (GenomeWeb News) ¯ Oxford Gene Technology yesterday said it has granted Phalanx Biotech Group a license to its Southern array patents.

The deal enables Taiwan-based Phalanx to sell arrays, including its whole-genome OneArray platform, for gene expression-profile studies in the US.

The license is valid for the patents’ lifetime.

Financial details were not disclosed.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.